2.5
2025

Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?

Show more: Authors information and Publication history
Authors Information

1Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
2Universitary Clinic of Immunoallergology, Faculty of Medicine, Universidade de Lisboa, Lisbon, Portugal

History

Published: 28 July 2023
Accepted: 27 July 2023
Received: 12 May 2023

KEY WORDS
Anti-IL-4/IL-13; atopic dermatitis; dupilumab; pruritus.

Table of Content: Vol. 57 (No. 3) 2025 May

European Annals of Allergy and Clinical Immunology | ©2026
Online ISSN: 2845-7285 (since 2024) · Print ISSN: 1764-1489 (discontinued in 2023)